RHEUMATOID ARTHRITIS: THE PROBLEMS OF REMISSION AND THERAPY RESISTANCE
Authors:
- Yu. A. OlyuninYOYu. A. Olyunin
Open Access
- 15 July 2018
- journal article
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 56 (3) , 263-271
Abstract
Rheumatoid arthritis (RA) is an immunoinflammatory (autoimmune) rheumatic disease of unknown etiology, which is characterized by chronic erosive arthritis and systemic visceral organ damage that results in early disability and shorter patient survival. Despite RA treatment advances associated with the design of novel drugs and the improvement of treatment strategies to achieve remission in many patients, there are still many theoretical and clinical problems concerning both the definition of the concept of remission, its characteristics and types and approaches to the optimum policy of symptomatic and pathogenetic drug therapy at different stages of the disease, the use of which will be able to rapidly induce and maintain remission in the long-term. Further investigations are needed to study the nature of heterogeneity of pathogenetic mechanisms of RA and approaches to early diagnosis, to improve methods for monitoring disease activity and biomarkers for the efficiency of and resistance to therapy and, finally, to develop differentiation therapy, including those related to a search for new therapeutic targets.Keywords
This publication has 93 references indexed in Scilit:
- An immunological biomarker to predict MTX response in early RAAnnals of the Rheumatic Diseases, 2014
- EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritisAnnals of the Rheumatic Diseases, 2013
- Development of a Multi-Biomarker Disease Activity Test for Rheumatoid ArthritisPLOS ONE, 2013
- An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progressionRheumatology, 2013
- Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activityArthritis Care & Research, 2012
- Evaluating disease activity in rheumatoid arthritis: Which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAIJoint Bone Spine, 2012
- Chronic widespread pain in the spectrum of rheumatological diseasesBest Practice & Research Clinical Rheumatology, 2011
- Prevalence of and predictive factors for sustained disease‐modifying antirheumatic drug–free remission in rheumatoid arthritis: Results from two large early arthritis cohortsArthritis & Rheumatism, 2009
- Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapseAnnals of the Rheumatic Diseases, 2008
- Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled trialArthritis & Rheumatism, 2007